IL90743A - Method for producing attenuated poliovirus and vaccine containing it - Google Patents

Method for producing attenuated poliovirus and vaccine containing it

Info

Publication number
IL90743A
IL90743A IL9074389A IL9074389A IL90743A IL 90743 A IL90743 A IL 90743A IL 9074389 A IL9074389 A IL 9074389A IL 9074389 A IL9074389 A IL 9074389A IL 90743 A IL90743 A IL 90743A
Authority
IL
Israel
Prior art keywords
poliovirus
cdna
rna
viral
sequences
Prior art date
Application number
IL9074389A
Other languages
English (en)
Other versions
IL90743A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL90743A0 publication Critical patent/IL90743A0/xx
Publication of IL90743A publication Critical patent/IL90743A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
IL9074389A 1989-06-08 1989-06-25 Method for producing attenuated poliovirus and vaccine containing it IL90743A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36361189A 1989-06-08 1989-06-08

Publications (2)

Publication Number Publication Date
IL90743A0 IL90743A0 (en) 1990-01-18
IL90743A true IL90743A (en) 1996-01-19

Family

ID=23430924

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9074389A IL90743A (en) 1989-06-08 1989-06-25 Method for producing attenuated poliovirus and vaccine containing it

Country Status (10)

Country Link
EP (1) EP0401421B1 (fr)
JP (1) JPH0310683A (fr)
AT (1) ATE132527T1 (fr)
AU (1) AU630099B2 (fr)
DE (1) DE68925356T2 (fr)
DK (1) DK340489A (fr)
ES (1) ES2084587T3 (fr)
FI (1) FI893346A7 (fr)
GR (1) GR3018670T3 (fr)
IL (1) IL90743A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004003045A1 (de) 2004-01-20 2005-08-18 Man Roland Druckmaschinen Ag Formatanpassung für Produktionsdaten

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8800100D0 (en) * 1988-01-05 1988-02-10 Almond J W Attenuated viruses
ATE121779T1 (de) * 1988-01-11 1995-05-15 American Cyanamid Co Nichtzurückschlagende rns-viren.
GB8901094D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses

Also Published As

Publication number Publication date
ES2084587T3 (es) 1996-05-16
DK340489D0 (da) 1989-07-10
JPH0310683A (ja) 1991-01-18
AU3713489A (en) 1990-12-13
DE68925356D1 (de) 1996-02-15
EP0401421A3 (fr) 1991-01-30
FI893346L (fi) 1990-12-09
DK340489A (da) 1990-12-09
FI893346A7 (fi) 1990-12-09
FI893346A0 (fi) 1989-07-10
EP0401421A2 (fr) 1990-12-12
GR3018670T3 (en) 1996-04-30
DE68925356T2 (de) 1996-09-05
IL90743A0 (en) 1990-01-18
AU630099B2 (en) 1992-10-22
EP0401421B1 (fr) 1996-01-03
ATE132527T1 (de) 1996-01-15

Similar Documents

Publication Publication Date Title
Andino et al. Poliovirus RNA synthesis utilizes an RNP complex formed around the 5′‐end of viral RNA.
Omata et al. Genetic analysis of the attenuation phenotype of poliovirus type 1
Venuti et al. Isolation and molecular cloning of a fast-growing strain of human hepatitis A virus from its double-stranded replicative form
EP0076847B1 (fr) ADNc REPRESENTANT DES SEQUENCES VIRALES ARN
RU2723353C1 (ru) Термочувствительные аттенуированные штаммы вируса ящура (fmdv), способ их конструирования и применение
Macadam et al. Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture
CN113564131B (zh) 柯萨奇病毒a6型毒株及其应用
CN113564130B (zh) 柯萨奇病毒a10型毒株及其应用
KR0178399B1 (ko) 장을 통해 전염되는 비a비b형 간염 바이러스 병원체 및 그것의 특유한 에피토프
EP0325768B1 (fr) Virus à ARN non retournant
CN109825517A (zh) 呼肠弧病毒家族病毒的疫苗病毒株的制造方法
Locher et al. Rapid detection and characterization of foot-and-mouth disease virus by restriction enzyme and nucleotide sequence analysis of PCR products
EP0496875B1 (fr) PROCEDES POUR PRODUIRE DES ARN VIRAUX A PARTIR D'ADNc
Meyer et al. Genetic variation of foot-and-mouth disease virus from field outbreaks to laboratory isolation
Cameron-Wilson et al. Nucleotide sequence of an attenuated mutant of coxsackievirus B3 compared with the cardiovirulent wildtype: assessment of candidate mutations by analysis of a revertant to cardiovirulence
US5358856A (en) Gene expression in mammalian cells using a cap independent 5' noncoding region
Spieker A new sequence variant of Coleus blumei viroid 1 from the Coleus blumei cultivar ‘Rainbow Gold’
Spicker et al. A new sequence variant of Coleus blumei viroid 3 from the Coleus blumei cultivar ‘Fairway Ruby’
McCarthy et al. Molecular characterisation of Australian bovine enteroviruses
EP0401421B1 (fr) Des virus d'ARN non réversibles
CN113564132B (zh) 柯萨奇病毒a16型毒株及其应用
Hema et al. Construction of an infectious cDNA clone of foot-and-mouth disease virus type O1BFS 1860 and its use in the preparation of candidate vaccine
Kanno et al. Viruses produced from complementary DNA of virulent and avirulent strains of swine vesicular disease viruses retain the in vivo and in vitro characteristics of the parental strain
Rezapkin et al. Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3
CN100404549C (zh) 埃可病毒30型衣壳蛋白(vp)的制备方法

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
RH Patent void